Canadian Phosphate Reveals 20.3 Million Options Outstanding with $0.25 Exercise Price Expiring in June 2028

Overview of Canadian Phosphate’s CP8O Options Register as at 24 June 2026

Canadian Phosphate Limited has disclosed a detailed distribution of its CP8O listed options as of 24 June 2026. These options trade on the ASX under the code CP8O and are linked to the company’s ordinary shares, which are listed under CP8. The report breaks down the number of holders, option units, and percentage ownership across five holding size brackets.

In total, 20,322,931 CP8O options are issued and held by 255 investors. Each option carries a fixed exercise price of $0.25 and shares a common expiry date of 26 June 2028. This expiry provides a two-year period from the snapshot date for holders to convert options into ordinary shares, subject to the instrument’s terms.

Concentration Among Large Holders: 45 Investors Own Over Three-Quarters of CP8O Options

The distribution reveals significant concentration at the top end of the register. The largest category—holders with between 100,001 and 9,999,999,999 options—comprises 45 holders controlling 15,513,799 options, or 76.34% of the total outstanding CP8O options. While such concentration is common in smaller listed instruments, it means that decisions by this relatively small group could substantially influence Canadian Phosphate’s capital structure.

If many of these large holders exercise their options before the June 2028 expiry, the company could receive considerable cash inflows based on the $0.25 exercise price. However, Canadian Phosphate has not provided guidance on expected exercise rates, proceeds, or the intended use of funds from potential option conversions. Investors should consider any exercise outcomes speculative at this stage.

Mid-Sized Holders Constitute the Majority of Investors

The bracket holding between 10,001 and 100,000 options is the largest by number of holders, with 117 investors owning 4,469,506 options—21.99% of the total. This group likely includes retail or smaller institutional investors who have built positions over time.

Combined, the two largest brackets (holders with over 10,000 options) account for 162 investors controlling 98.33% of all options. The remaining 93 holders, spread across the three smaller brackets (1 to 10,000 options), collectively hold just 1.67% of the CP8O options. Despite their small share, these investors reflect broader market interest in the company’s listed options.

Limited Exposure Among Smaller Holders

At the lower end, 27 holders own between 1 and 1,000 CP8O options each, totaling 12,553 options or 0.06% of the issued options. The next bracket, 1,001 to 5,000 options, includes 42 holders with 128,239 options (0.63%). The 5,001 to 10,000 option bracket consists of 24 holders with 198,834 options (0.98%).

These smaller holdings may represent investors who acquired options through earlier capital raisings or entitlement offers, or those who have reduced larger positions. The company did not specify the issuance history or retail investor proportion within the CP8O register. The rounding error across all brackets is reported as 0.00%, indicating accuracy in totals.

Exercise Price of $0.25 in Relation to Canadian Phosphate’s Share Price

The CP8O options have a fixed exercise price of $0.25, requiring holders to pay this amount per option to convert into one ordinary CP8 share. Whether this price is at a premium, discount, or parity to the current CP8 share price is crucial for holders deciding if and when to exercise.

The update did not provide the current CP8 share price or analysis comparing it to the exercise price. Investors should consult independent market data to determine if their options are in-the-money or out-of-the-money.

Expiry Date of 26 June 2028 Establishes a Clear Decision Deadline

The CP8O options expire on 26 June 2028, after which unexercised options will lapse with no value. From the snapshot date of 24 June 2026, holders have approximately two years to decide on exercising.

Expiry dates often lead to increased trading activity in both options and underlying shares as holders evaluate the economic benefit of exercising. Canadian Phosphate has not announced any expected milestones before the expiry, and no timeline should be inferred from this disclosure alone.

Implications for Canadian Phosphate’s Capital Structure

The presence of 20,322,931 listed options alongside ordinary shares means potential dilution for existing CP8 shareholders. Full exercise of all CP8O options at $0.25 each would create up to 20,322,931 new shares and generate approximately $5,080,732.75 in cash proceeds, although the company did not confirm this figure or provide a fully diluted share count.

Canadian Phosphate did not disclose its total ordinary shares outstanding in this update. Investors seeking a comprehensive view of the capital structure should consult the latest annual report or other capital disclosures. This options register snapshot reflects only the CP8O instrument at a point in time.

Comparison of CP8O Options to Typical ASX Small-Cap Instruments

Listed options are common among smaller ASX-listed companies, often issued during capital raisings, IPOs, or entitlement offers. They offer early investors leveraged exposure to future share price gains and provide a potential funding source if exercised.

The CP8O options, with a fixed exercise price, expiry date, and listed trading, conform to standard market practices. The 255-holder register size aligns with many small-cap ASX companies. The company did not provide historical or benchmark comparisons, so any broader analysis should be considered independent commentary.

Outlook and Investor Considerations Ahead of 2028 Expiry

CP8O option holders and Canadian Phosphate shareholders should watch for developments affecting the company’s operations, capital structure, or share price, as these could influence the attractiveness of exercising options at $0.25. Positive progress may impact decisions by the 45 largest holders controlling over three-quarters of the options.

No corporate actions, capital raises, or operational announcements were disclosed in this update. The next formal update on the CP8O register will likely be the subsequent periodic holder distribution notice. Investors are advised to review all company communications carefully and seek advice from licensed financial professionals before making decisions regarding CP8 or CP8O holdings.